In vitro effects of lymphoblastoid interferon on lymphocyte activation and cell-mediated cytolysis in patients with chronic hepatitis B virus infection
- PMID: 3110263
- DOI: 10.1016/s0168-8278(86)80131-3
In vitro effects of lymphoblastoid interferon on lymphocyte activation and cell-mediated cytolysis in patients with chronic hepatitis B virus infection
Abstract
In addition to a direct anti-viral effect, interferons have important immunological properties including effects on cell-mediated immunity and antibody production as well as cell-mediated cytolysis. In chronic hepatitis B virus infection the host immune system is important for the elimination of replicating virus and in addition to directly inhibiting hepatitis B virus replication, interferons may affect host immune responses. We investigated the effect of lymphoblastoid interferon in vitro on lymphocyte activation and cell-mediated cytolysis in patients with chronic hepatitis B virus infection. The proliferative response to the mitogen PHA was significantly impaired in patients compared to controls. In addition supernatants of cultured mononuclear cells from patients stimulated with PHA contained less interleukin-2 activity than controls while the proportion of stimulated mononuclear cells expressing the interleukin-2 receptor was also reduced in patients. Prior incubation with 10(3) U ml-1 lymphoblastoid interferon increased both interleukin-2 activity and interleukin-2 receptor expression in patients and controls, although in patients the response was less marked. In contrast the proliferative response was unaffected. Natural killer cell activity against K562 cells was similar in patients and controls which in both groups was significantly augmented by prior incubation with 10(3) U ml-1 lymphoblastoid interferon; the increase was inversely proportional to baseline activity. In contrast incubation of target or effector cells with interferon did not augment T-cell cytotoxicity against autologous hepatocytes. The effects of lymphoblastoid interferon in vitro, were modest, but subtle changes in immunological status in addition to a direct effect on viral replication may be relevant to eventual clearance of the hepatitis B virus.
Similar articles
-
Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid.Liver. 1991 Apr;11(2):106-13. doi: 10.1111/j.1600-0676.1991.tb00500.x. Liver. 1991. PMID: 1646927
-
In vitro effect of lymphoblastoid alpha-interferon on subpopulations of effector cells mediating cytotoxicity for autologous hepatocytes in hepatitis B and non-A, non-B.Int J Immunopharmacol. 1986;8(8):887-91. doi: 10.1016/0192-0561(86)90089-5. Int J Immunopharmacol. 1986. PMID: 3100465
-
Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.J Viral Hepat. 2015 Mar;22(3):335-45. doi: 10.1111/jvh.12299. Epub 2014 Sep 3. J Viral Hepat. 2015. PMID: 25186004
-
Immune mechanisms and the action of interferon in chronic hepatitis B virus infection.Immunol Commun. 1978;7(4):371-82. doi: 10.3109/08820137809047623. Immunol Commun. 1978. PMID: 352919 Review.
-
[Interferon treatment of chronic viral hepatitis].Ther Umsch. 1992 May;49(5):302-9. Ther Umsch. 1992. PMID: 1377840 Review. German.
Cited by
-
Hepatology.Postgrad Med J. 1991 Aug;67(790):719-41. doi: 10.1136/pgmj.67.790.719. Postgrad Med J. 1991. PMID: 1754523 Free PMC article. Review. No abstract available.
-
Disease Pathways and Mechanisms of Potential Drug Targets.Clin Liver Dis (Hoboken). 2018 Aug 22;12(1):12-18. doi: 10.1002/cld.735. eCollection 2018 Jul. Clin Liver Dis (Hoboken). 2018. PMID: 30988903 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical